Abstract:R-(-)-mandelic acid is an important multifunctional pharmaceutical intermediate in the preparation of chiral drugs. A sp. strain by1 from 18 strains of Saccharomyces cerevisiae, Lactoballius, Streptococcus faecalis, Candida albicans had been screened for transforming phenylglyoxilic acid to R-(-)-mandelic acid. In this article, to study further the asymmetric bioreduction of phenylglyoxylic acid to mandelic acid by Saccharomyces cerevisiae sp. strain by1, the effect of biochemical factors on the conversion efficiency of substrate phenylglyoxylic acid and enantiomeric excess of product R-mandelic acid were investigated in detail. For some conditions tested in our experiments, the sp. strain by1 showed very high enantioselectivity toward the bioreduction of the substrates. The enantiomeric excess value of desired product R-(-)-mandelic acid reached up to 94.0%. Whereas, the conversion of substrate and the yield of product mandelic acid were influenced evidently by the environmental factors. The substrate conversion and the yield of product decreased sharply with the increase of initial substrate concentration up to 20 mmol/L. The high concentration of substrates inhibits strongly the activity of redoxase of yeast cells. Under the optimal conditions: pH 6.5, 32oC, initial concentration 15 mmol/L, absolute anaerobic cultivation 28 h, the substrate conversion rate of 97.0% and yield of product mandelic acid of 96.1% and enantiomeric excess value of R-(-)-mandelic acid of 95.1% could been obtained. This research paces the way for economic preparation of chiral R-(-)-mandelic acid.

Influencing Factors of Asymmetric Biosynthesis of R-(-)-mandelic Acid

Co-immobilization of Short-Chain Dehydrogenase/Reductase and Glucose Dehydrogenase for the Efficient Production of (±)-Ethyl Mandelate

Improving the Stereoselectivity of Asymmetric Reduction of 3-Oxo Ester to 3-Hydroxy Ester with Pretreatments on Bakers'Yeast

R-(-)-acetyl-o-mandelic acid preparation via enzymatic dynamic kinetic resolution

Enantioseparation of chiral mandelic acid derivatives by supercritical fluid chromatography

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

Enantiocomplementary preparation of (S)- and (R)-mandelic acid derivatives via α-hydroxylation of 2-arylacetic acid derivatives and reduction of α-ketoester using microbial whole cells

Optimization of fermentation conditions for production of a novel antifungal metabolite by response surface methodology

Fermentation process and kinetics of novel antifungal antibiotic production

Review on Biocatalytic Synthesis of R-mandelic Acid

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Chiral Ligand Exchange Countercurrent Chromatography: Equilibrium Model Study on Enantioseparation of Mandelic Acid.

Production of Retinoic Acid by Engineered Saccharomyces Cerevisiae Using an Endogenous Aldehyde Dehydrogenase.

Investigating strain dependency in the production of aromatic compounds in Saccharomyces cerevisiae

Improved Enantioselectivity of E. Coli BioH in Kinetic Resolution of Methyl (S)-3-cyclohexene-1-carboxylate by Combinatorial Modulation of Steric and Aromatic Interactions

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Efficient production of (R)-(−)-mandelic acid using glutaraldehyde cross-linked Escherichia coli cells expressing Alcaligenes sp. nitrilase

Asymmetric Reduction of Chloroacetophenones to Produce Chiral Alcohols with Microorganisms

Electric-field-assisted in situ separation of mandelic acid in an enzymatic milli-reactor improves the control of reaction conversion and enhances the enantiomeric ratio

Biocatalytic Desymmetrization of Prochiral 3‐Aryl and 3‐Arylmethyl Glutaramides: Different Remote Substituent Effect on Catalytic Efficiency and Enantioselectivity

Asymmetric Synthesis of Both Enantiomers of Dimethyl 2-Methylsuccinate by the Ene-Reductase-Catalyzed Reduction at High Substrate Concentration